Provided By PR Newswire
Last update: Jul 7, 2025
Industry veteran with proven track record in neurorehabilitation and fundraising to lead next phase of growth; Co-founder Brian Harris transitions to Chief Scientific Officer
Read more at prnewswire.com0.726
-0.02 (-2.55%)
Find more stocks in the Stock Screener